CORTCorcept Therapeutics Inc
Earnings
When Corcept Therapeutics Inc reports, what it reported each quarter, and how the stock took the results.
66 quarters. Jun 30, 2010 to Sep 30, 2026. USD.
Next results · Q4 2026Projected
Feb 23, after the close
Tue, Feb 23, 2027in 97 days
Projected from its last 8 releases. The company has not named the day yet.
- Quarter
- Q4 2026 · Ends about Dec 31, 2026
- 10-K window
- Feb 12 – Mar 1
Read against Q4 2025
The same quarter a year earlier, the figures the next ones will be compared with. Thaler holds no estimates.
- Revenue
- $202.13M
- Revenue, change from a year earlier: Q3 2026 +64.0%, Q2 2026 +31.7%, Q1 2026 +4.9%, Q4 2025 +11.1%
- Net income
- $24.29M
- Net income, change from a year earlier: Q3 2026 +544.6%, Q2 2026 +22.3%, Q1 2026 n/m, Q4 2025 −21.0%
- EPS
- —
- EPS, change from a year earlier: Q3 2026 +531.3%, Q2 2026 +24.1%, Q1 2026 n/m, Q3 2025 −61.0%
Latest results
- Revenue
- $340.47M
- +64.0%
- Net income
- $126.78M
- +544.6%
- EPS
- $1.01
- +531.3%
- Revenue
- $256.15M
- +31.7%
- Net income
- $42.99M
- +22.3%
- EPS
- $0.36
- +24.1%
- Revenue
- $164.90M
- +4.9%
- Net income
- -$31.76M
- N/M
- EPS
- -$0.30
- N/M
- Revenue
- $202.13M
- +11.1%
- Net income
- $24.29M
- −21.0%
- EPS
- —
- —
All quarters
| Period | Ended | Announced | Filed | Lag | Form | Revenue | Δ yoy | EPS dil. | Move | Source trail |
|---|---|---|---|---|---|---|---|---|---|---|
| FY 2026 | ||||||||||
| Q3 2026 | Sep 30, 2026 | Nov 3, 2026 · after-hours | Nov 3, 2026 | 34 d | 10-Q | $340.47M | +64.0% | $1.01 | 3.3% | |
| Q2 2026 | Jun 30, 2026 | Jul 29, 2026 · after-hours | Jul 29, 2026 | 29 d | 10-Q | $256.15M | +31.7% | $0.36 | +27.3% | |
| Q1 2026 | Mar 31, 2026 | Apr 30, 2026 · after-hours | Apr 30, 2026 | 30 d | 10-Q | $164.90M | +4.9% | -$0.30 | +10.5% | |
| FY 2025 | ||||||||||
| Q4 2025derived | Dec 31, 2025 | Feb 24, 2026 · after-hours | Feb 24, 2026 | 55 d | 10-K | $202.13M | +11.1% | — | 0.7% | |
| Q3 2025 | Sep 30, 2025 | Nov 4, 2025 · after-hours | Nov 4, 2025 | 35 d | 10-Q | $207.64M | +13.7% | $0.16 | +8.0% | |
| Q2 2025 | Jun 30, 2025 | Jul 31, 2025 · after-hours | Jul 31, 2025 | 31 d | 10-Q | $194.43M | +18.7% | $0.29 | +2.6% | |
| Q1 2025 | Mar 31, 2025 | May 5, 2025 · after-hours | May 5, 2025 | 35 d | 10-Q | $157.21M | +7.1% | $0.17 | 4.5% | |
| FY 2024 | ||||||||||
| Q4 2024derived | Dec 31, 2024 | Feb 26, 2025 · after-hours | Feb 26, 2025 | 57 d | 10-K | $181.89M | +34.3% | — | 5.6% | |
| Q3 2024 | Sep 30, 2024 | Oct 30, 2024 · after-hours | Oct 30, 2024 | 30 d | 10-Q | $182.55M | +47.7% | $0.41 | +4.4% | |
| Q2 2024 | Jun 30, 2024 | Jul 29, 2024 · after-hours | Jul 29, 2024 | 29 d | 10-Q | $163.80M | +39.1% | $0.32 | — | |
| Q1 2024 | Mar 31, 2024 | May 1, 2024 · after-hours | May 1, 2024 | 31 d | 10-Q | $146.81M | +39.0% | $0.25 | +5.1% | |
| FY 2023 | ||||||||||
| Q4 2023derived | Dec 31, 2023 | Feb 15, 2024 · after-hours | Feb 15, 2024 | 46 d | 10-K | $135.41M | +31.4% | — | 7.2% | |
| Q3 2023 | Sep 30, 2023 | Nov 1, 2023 · after-hours | Nov 1, 2023 | 32 d | 10-Q | $123.60M | +21.5% | $0.28 | 8.8% | |
| Q2 2023 | Jun 30, 2023 | Aug 2, 2023 · after-hours | Aug 2, 2023 | 33 d | 10-Q | $117.72M | +13.9% | $0.25 | +24.9% | |
| Q1 2023 | Mar 31, 2023 | May 3, 2023 · after-hours | May 3, 2023 | 33 d | 10-Q | $105.65M | +12.8% | $0.14 | +6.8% | |
| FY 2022 | ||||||||||
| Q4 2022derived | Dec 31, 2022 | Feb 28, 2023 · after-hours | Feb 28, 2023 | 59 d | 10-K | $103.06M | +4.3% | — | 4.7% | |
| Q3 2022 | Sep 30, 2022 | Nov 3, 2022 · after-hours | Nov 3, 2022 | 34 d | 10-Q | $101.73M | +5.8% | $0.30 | 10.7% | |
| Q2 2022 | Jun 30, 2022 | Aug 3, 2022 · after-hours | Aug 4, 2022 | 35 d | 10-Q | $103.39M | +12.9% | $0.24 | 1.2% | |
| Q1 2022 | Mar 31, 2022 | May 5, 2022 · after-hours | May 5, 2022 | 35 d | 10-Q | $93.69M | +17.9% | $0.20 | — | |
| FY 2021 | ||||||||||
| Q4 2021derived | Dec 31, 2021 | Feb 15, 2022 · after-hours | Feb 15, 2022 | 46 d | 10-K | $98.82M | +15.3% | — | — | |
| Q3 2021 | Sep 30, 2021 | Nov 3, 2021 · after-hours | Nov 3, 2021 | 34 d | 10-Q | $96.13M | +11.4% | $0.24 | — | |
| Q2 2021 | Jun 30, 2021 | Jul 29, 2021 · after-hours | Jul 29, 2021 | 29 d | 10-Q | $91.59M | +3.4% | $0.21 | — | |
| Q1 2021 | Mar 31, 2021 | May 6, 2021 · after-hours | May 6, 2021 | 36 d | 10-Q | $79.44M | −14.8% | $0.18 | 7.8% | |
| FY 2020 | ||||||||||
| Q4 2020 | Dec 31, 2020 | Feb 23, 2021 · after-hours | Feb 23, 2021 | 54 d | 10-K | $85.74M | −2.5% | $0.20 | 0.5% | |
| Q3 2020 | Sep 30, 2020 | Nov 3, 2020 · after-hours | Nov 3, 2020 | 34 d | 10-Q | $86.33M | +5.9% | $0.17 | +7.7% | |
| Q2 2020 | Jun 30, 2020 | Aug 4, 2020 · after-hours | Aug 4, 2020 | 35 d | 10-Q | $88.57M | +22.6% | $0.23 | — | |
| Q1 2020 | Mar 31, 2020 | May 4, 2020 · after-hours | May 4, 2020 | 34 d | 10-Q | $93.25M | +43.8% | $0.25 | — | |
| FY 2019 | ||||||||||
| Q4 2019 | Dec 31, 2019 | Feb 20, 2020 · after-hours | Feb 24, 2020 | 55 d | 10-K | $87.90M | +31.5% | $0.24 | — | |
| Q3 2019 | Sep 30, 2019 | Nov 7, 2019 · after-hours | Nov 7, 2019 | 38 d | 10-Q | $81.51M | +26.5% | $0.22 | — | |
| Q2 2019 | Jun 30, 2019 | Aug 1, 2019 · after-hours | Aug 1, 2019 | 32 d | 10-Q | $72.26M | +16.0% | $0.17 | +12.9% | |
| Q1 2019 | Mar 31, 2019 | May 9, 2019 · after-hours | May 9, 2019 | 39 d | 10-Q | $64.83M | +12.4% | $0.15 | 9.9% | |
| FY 2018 | ||||||||||
| Q4 2018 | Dec 31, 2018 | Feb 25, 2019 · after-hours | Feb 26, 2019 | 57 d | 10-K | $66.83M | +25.4% | $0.18 | +5.3% | |
| Q3 2018 | Sep 30, 2018 | Nov 1, 2018 · after-hours | Nov 2, 2018 | 33 d | 10-Q | $64.45M | +50.7% | $0.14 | — | |
| Q2 2018 | Jun 30, 2018 | Aug 9, 2018 · after-hours | Aug 9, 2018 | 40 d | 10-Q | $62.31M | +75.2% | $0.14 | 5.2% | |
| Q1 2018 | Mar 31, 2018 | May 8, 2018 · after-hours | May 9, 2018 | 39 d | 10-Q | $57.66M | +108.9% | $0.14 | 1.9% | |
| FY 2017 | ||||||||||
| Q4 2017 | Dec 31, 2017 | Feb 22, 2018 · after-hours | Feb 28, 2018 | 59 d | 10-K | $53.28M | +123.8% | $0.77 | 3.2% | |
| Q3 2017 | Sep 30, 2017 | — | Nov 3, 2017 | 34 d | 10-Q | $42.76M | +96.8% | $0.11 | 11.7% | |
| Q2 2017 | Jun 30, 2017 | — | Aug 2, 2017 | 33 d | 10-Q | $35.56M | +80.3% | $0.10 | +13.9% | |
| Q1 2017 | Mar 31, 2017 | — | May 2, 2017 | 32 d | 10-Q | $27.60M | +71.8% | $0.04 | 1.5% | |
| FY 2016 | ||||||||||
| Q4 2016 | Dec 31, 2016 | — | Mar 6, 2017 | 65 d | 10-K | $23.81M | +59.1% | $0.04 | +16.8% | |
| Q3 2016 | Sep 30, 2016 | — | Nov 2, 2016 | 33 d | 10-Q | $21.73M | +63.8% | $0.02 | +14.0% | |
| Q2 2016 | Jun 30, 2016 | — | Aug 3, 2016 | 34 d | 10-Q | $19.72M | +65.0% | $0.01 | — | |
| Q1 2016 | Mar 31, 2016 | — | May 4, 2016 | 34 d | 10-Q | $16.06M | +59.0% | $0.00 | — | |
| FY 2015 | ||||||||||
| Q4 2015 | Dec 31, 2015 | — | Mar 10, 2016 | 70 d | 10-K | $14.97M | +66.1% | $0.01 | +2.6% | |
| Q3 2015 | Sep 30, 2015 | — | Nov 6, 2015 | 37 d | 10-Q | $13.26M | +82.1% | -$0.01 | — | |
| Q2 2015 | Jun 30, 2015 | — | Aug 7, 2015 | 38 d | 10-Q | $11.96M | +104.3% | -$0.02 | — | |
| Q1 2015 | Mar 31, 2015 | — | May 8, 2015 | 38 d | 10-Q | $10.10M | +129.3% | -$0.05 | — | |
| FY 2014 | ||||||||||
| Q4 2014 | Dec 31, 2014 | — | — | — | — | $9.01M | +119.0% | -$0.04 | — | |
| Q3 2014 | Sep 30, 2014 | — | — | — | — | $7.28M | +176.5% | -$0.06 | — | |
| Q2 2014 | Jun 30, 2014 | — | — | — | — | $5.85M | +209.4% | -$0.07 | — | |
| Q1 2014 | Mar 31, 2014 | — | — | — | — | $4.41M | +156.6% | -$0.14 | — | |
| FY 2013 | ||||||||||
| Q4 2013 | Dec 31, 2013 | — | — | — | — | $4.12M | +198.8% | -$0.11 | — | |
| Q3 2013 | Sep 30, 2013 | — | — | — | — | $2.63M | +149.7% | -$0.11 | — | |
| Q2 2013 | Jun 30, 2013 | — | — | — | — | $1.89M | +116.1% | -$0.12 | — | |
| Q1 2013 | Mar 31, 2013 | — | — | — | — | $1.72M | — | -$0.12 | — | |
| FY 2012 | ||||||||||
| Q4 2012 | Dec 31, 2012 | — | — | — | — | $1.38M | — | -$0.11 | — | |
| Q3 2012 | Sep 30, 2012 | — | — | — | — | $1.06M | — | -$0.08 | — | |
| Q2 2012 | Jun 30, 2012 | — | — | — | — | $875.00K | — | -$0.09 | — | |
| Q1 2012 | Mar 31, 2012 | — | — | — | — | — | — | -$0.13 | — | |
| FY 2011 | ||||||||||
| Q4 2011 | Dec 31, 2011 | — | — | — | — | — | — | -$0.12 | — | |
| Q3 2011 | Sep 30, 2011 | — | — | — | — | — | — | -$0.08 | — | |
| Q2 2011 | Jun 30, 2011 | — | — | — | — | — | — | -$0.11 | — | |
| Q1 2011 | Mar 31, 2011 | — | — | — | — | — | — | -$0.09 | — | |
| FY 2010 | ||||||||||
| Q4 2010derived | Dec 31, 2010 | — | — | — | — | — | — | — | — | |
| Q3 2010 | Sep 30, 2010 | — | — | — | — | — | — | -$0.10 | — | |
| Q2 2010 | Jun 30, 2010 | — | — | — | — | — | — | -$0.09 | — | |
Earlier years, FY 2010 to FY 2023The latest three years
Move: the stock from the last close before the release to the first close after it. Last sale prices: Data provided for free by IEX. By accessing or using IEX Historical Data, you agree to the IEX Historical Data Terms of Use.
Source filings
Provenance
ProvenanceData status and checks
Corcept Therapeutics Inc · CIK 1088856 · Engraved from SEC EDGAR